In addition, human studies reported serum or urinary NGAL to be useful for detecting AKI at early stages in multiple clinical conditions, including sepsis, septic shock, and cardiac surgery, and also to identify AKI early in patients with liver cirrhosis and to differentiate ATN from HRS [11,24,25]. Here, LCN2 is linked to acute kidney injury.